Literature DB >> 18069056

Modulation of natural killer cells by human cytomegalovirus.

Gavin W G Wilkinson1, Peter Tomasec, Richard J Stanton, Melanie Armstrong, Virginie Prod'homme, Rebecca Aicheler, Brian P McSharry, Carole R Rickards, Daniel Cochrane, Sian Llewellyn-Lacey, Eddie C Y Wang, Cora A Griffin, Andrew J Davison.   

Abstract

Human cytomegalovirus (HCMV) causes lifelong, persistent infections and its survival is under intense, continuous selective pressure from the immune system. A key aspect of HCMV's capacity for survival lies in immune avoidance. In this context, cells undergoing productive infection exhibit remarkable resistance to natural killer (NK) cell-mediated cytolysis in vitro. To date, six genes encoding proteins (UL16, UL18, UL40, UL83, UL141 and UL142) and one encoding a microRNA (miR-UL112) have been identified as capable of suppressing NK cell recognition. Even though HCMV infection efficiently activates expression of ligands for the NK cell activating receptor NKG2D, at least three functions (UL16, UL142 and miR-UL112) act in concert to suppress presentation of these ligands on the cell surface. Although HCMV downregulates expression of endogenous MHC-I, it encodes an MHC-I homologue (UL18) and also upregulates the expression of cellular HLA-E through the action of UL40. The disruption of normal intercellular connections exposes ligands for NK cell activating receptors on the cell surface, notably CD155. HCMV overcomes this vulnerability by encoding a function (UL141) that acts post-translationally to suppress cell surface expression of CD155. The mechanisms by which HCMV systematically evades (or, more properly, modulates) NK cell recognition constitutes an area of growing understanding that is enhancing our appreciation of the basic mechanisms of NK cell function in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18069056      PMCID: PMC2843162          DOI: 10.1016/j.jcv.2007.10.027

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  39 in total

1.  Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

Authors:  N Jan Chalupny; Annie Rein-Weston; Stephanie Dosch; David Cosman
Journal:  Biochem Biophys Res Commun       Date:  2006-05-24       Impact factor: 3.575

2.  Identification and characterization of human cytomegalovirus-encoded microRNAs.

Authors:  Finn Grey; Andy Antoniewicz; Edwards Allen; Julie Saugstad; Andy McShea; James C Carrington; Jay Nelson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

Authors:  Gopalakrishnan M Venkataraman; Dominic Suciu; Veronika Groh; Jeremy M Boss; Thomas Spies
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Human cytomegalovirus expresses novel microRNAs during productive viral infection.

Authors:  Walter Dunn; Phong Trang; Qiu Zhong; Edward Yang; Christopher van Belle; Fenyong Liu
Journal:  Cell Microbiol       Date:  2005-11       Impact factor: 3.715

5.  Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha2 domains.

Authors:  Jessica Spreu; Thilo Stehle; Alexander Steinle
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

6.  Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.

Authors:  John M Routes; Sharon Ryan; Kristin Morris; Rayna Takaki; Adelheid Cerwenka; Lewis L Lanier
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

7.  Adenovirus vector delivery stimulates natural killer cell recognition.

Authors:  Peter Tomasec; Eddie C Y Wang; Veronika Groh; Thomas Spies; Brian P McSharry; Rebecca J Aicheler; Richard J Stanton; Gavin W G Wilkinson
Journal:  J Gen Virol       Date:  2007-04       Impact factor: 3.891

8.  The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

Authors:  Virginie Prod'homme; Cora Griffin; Rebecca J Aicheler; Eddie C Y Wang; Brian P McSharry; Carole R Rickards; Richard J Stanton; Leszek K Borysiewicz; Miguel López-Botet; Gavin W G Wilkinson; Peter Tomasec
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

9.  Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression.

Authors:  R J Stanton; B P McSharry; C R Rickards; E C Y Wang; P Tomasec; G W G Wilkinson
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis.

Authors:  Mark R Wills; Omodele Ashiru; Matthew B Reeves; Georgina Okecha; John Trowsdale; Peter Tomasec; Gavin W G Wilkinson; John Sinclair; J G Patrick Sissons
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

View more
  126 in total

1.  An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.

Authors:  Seema Shafi; Pierre Vantourout; Graham Wallace; Ayman Antoun; Robert Vaughan; Miles Stanford; Adrian Hayday
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

Review 2.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 3.  Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors.

Authors:  Michal Pyzik; Eve-Marie Gendron-Pontbriand; Nassima Fodil-Cornu; Silvia M Vidal
Journal:  Mamm Genome       Date:  2010-09-30       Impact factor: 2.957

4.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 5.  Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

Review 6.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 8.  Cytomegalovirus microRNAs.

Authors:  Lars Dölken; Sébastien Pfeffer; Ulrich H Koszinowski
Journal:  Virus Genes       Date:  2009-03-17       Impact factor: 2.332

9.  Identification and Function of MicroRNAs Encoded by Herpesviruses.

Authors:  Zhi-Qiang Bai; Xiu-Fen Lei; Lin-Ding Wang; Shou-Jiang Gao
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

10.  Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation.

Authors:  Luca Bruno; Mirko Cortese; Giuseppina Monda; Michela Gentile; Stefano Calò; Francesca Schiavetti; Luisanna Zedda; Elena Cattaneo; Diego Piccioli; Mary Schaefer; Eugenio Notomista; Domenico Maione; Andrea Carfì; Marcello Merola; Yasushi Uematsu
Journal:  Immunol Cell Biol       Date:  2016-05-19       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.